A Safer, Smarter Way to Check Your Liver Health.
Fibroscan is a revolutionary, non-invasive medical device used to assess liver stiffness—an indicator of liver scarring (fibrosis). This quick and painless test uses transient elastography to measure how stiff your liver is, providing vital insight into conditions like fatty liver disease, hepatitis, and cirrhosis. Unlike traditional liver biopsies, Fibroscan offers results in minutes without needles or discomfort.
Fibroscan sends a painless vibration (elastic wave) through the liver using ultrasound technology. The speed at which this wave travels helps determine liver stiffness—faster waves mean a stiffer liver, which could indicate fibrosis.
Preparation: The patient lies on their back with the right arm raised behind the head. This position exposes the liver, allowing the probe to make accurate contact with the skin over the liver area.
Scanning: A small probe is gently placed on the skin above the liver. The device emits harmless vibrations that travel through liver tissue, measuring its stiffness and fat content.
Measurement: Multiple readings are taken within 5–10 minutes. The process is quick, painless, and does not require anesthesia or special recovery time.
Results: Patients receive immediate feedback showing the stage of liver fibrosis and the amount of fat in the liver. These results help doctors assess liver health and plan personalized treatment strategies.
Applications:
Chronic Hepatitis B and C: Helps determine the need for antiviral therapy and track treatment effectiveness.
Non-Alcoholic Fatty Liver Disease (NAFLD): Evaluates fat buildup and fibrosis to guide lifestyle modifications, diet, exercise, and medications.
Alcoholic Liver Disease: Detects early liver damage from alcohol use, allowing timely intervention and counseling.
Cirrhosis and Liver Fibrosis: Monitors disease progression, stages fibrosis, and helps predict prognosis without repeated invasive tests.
Chronic Hepatitis B and C: Fibroscan allows doctors to measure liver stiffness, which reflects the extent of liver damage. This helps in deciding the need for antiviral therapy and tracking how well the treatment is working over time—without performing a painful biopsy.
Non-Alcoholic Fatty Liver Disease (NAFLD): Common in people with obesity, diabetes, or metabolic syndrome, NAFLD can progress to liver fibrosis. Fibroscan provides a quick, accurate assessment of fat accumulation and scarring, helping doctors recommend personalized lifestyle changes, diet, exercise, or medications.
Alcoholic Liver Disease: Long-term alcohol use can silently damage the liver. Fibroscan detects early signs of fibrosis, enabling timely medical support and counseling to prevent further liver deterioration.
Cirrhosis and Liver Fibrosis: For patients with advanced liver disease, Fibroscan helps stage fibrosis and cirrhosis. Regular monitoring with this non-invasive tool allows doctors to predict disease progression, plan treatment, and avoid repeated invasive biopsies.
Fibroscan is widely regarded as a safe, non-invasive, and well-tolerated diagnostic tool. Unlike traditional liver biopsies, it does not involve needles, anesthesia, or surgical procedures, making it a preferred option for many patients. However, like any medical procedure, it’s important to understand any potential limitations or risks associated with its use—even if they are minimal.